Kardium pulls in an additional $250M to advance PFA tech
Kardium, a Canada-based company developing a pulsed field ablation treatment for atrial fibrillation, said it raised another $250 million to support the launch of its Globe system.
The financing follows a $104 million funding round in June 2024 that enabled Kardium to complete its pivotal trial for the device.
The new funds will allow the medical device maker to expand its manufacturing facilities and production capacity and establish a clinical support and commercial team as it prepares to launch the system later this year.
Kardium is preparing to enter an emerging PFA field that has seen physicians switch to the new technology en masse.
Driving the rapid adoption is a reduced risk of injury with PFA compared to traditional cardiac ablation methods for treating AFib, an abnormal heart rhythm that can lead to stroke. PFA has been shown to reduce the risk of damage to nearby structures such as the esophagus or phrenic nerve during the ablation procedure.
Kardium said one-year results from its Pulsar clinical trial, presented at the Heart Rhythm Society meeting in April, showed a 78% 12-month effectiveness rate in patients with intermittent AFib and no device-related primary safety events.
The new funding will also enable Kardium to pursue regulatory approvals for the Globe system and run further clinical research for additional applications for the technology, the company said.
Kardium will be entering a market where Boston Scientific and Medtronic are enjoying strong demand for their PFA devices. Johnson & Johnson has also joined the race, and Abbott anticipates approval for a PFA system next year.
Kardium's investors include Janus Henderson Investors, Qatar Investment Authority, MMCAP, Piper Heartland Healthcare Capital, Eventide Asset Management and Eckuity Capital.
Existing investors that participated in the new round include funds and accounts advised by T. Rowe Price and Durable Capital Partners. The financing also includes an equity investment from a strategic investor.
Recommended Reading
Boston Scientific is 'very bullish' on 2025 despite $200M tariff hit
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Boston Scientific (BSX) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Boston Scientific (BSX) closed at $102.41, marking a -1.37% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.07% for the day. Meanwhile, the Dow experienced a drop of 0.37%, and the technology-dominated Nasdaq saw an increase of 0.03%. The medical device manufacturer's shares have seen an increase of 3.79% over the last month, surpassing the Medical sector's loss of 1.3% and falling behind the S&P 500's gain of 3.94%. Investors will be eagerly watching for the performance of Boston Scientific in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 23, 2025. The company's upcoming EPS is projected at $0.72, signifying a 16.13% increase compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $4.89 billion, indicating a 18.69% growth compared to the corresponding quarter of the prior year. For the full year, the Zacks Consensus Estimates are projecting earnings of $2.91 per share and revenue of $19.5 billion, which would represent changes of +15.94% and +16.42%, respectively, from the prior year. Investors should also note any recent changes to analyst estimates for Boston Scientific. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate has moved 0.05% higher within the past month. Currently, Boston Scientific is carrying a Zacks Rank of #2 (Buy). Digging into valuation, Boston Scientific currently has a Forward P/E ratio of 35.62. For comparison, its industry has an average Forward P/E of 19.12, which means Boston Scientific is trading at a premium to the group. Meanwhile, BSX's PEG ratio is currently 2.7. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Medical - Products industry had an average PEG ratio of 2.26. The Medical - Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 89, putting it in the top 37% of all 250+ industries. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
an hour ago
- Yahoo
Lightspeed Commerce Inc. (LSPD) Increases Despite Market Slip: Here's What You Need to Know
Lightspeed Commerce Inc. (LSPD) ended the recent trading session at $11.78, demonstrating a +1.2% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.07%. Meanwhile, the Dow lost 0.37%, and the Nasdaq, a tech-heavy index, added 0.03%. Heading into today, shares of the company had lost 0.26% over the past month, lagging the Computer and Technology sector's gain of 5.58% and the S&P 500's gain of 3.94%. Analysts and investors alike will be keeping a close eye on the performance of Lightspeed Commerce Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be $0.11, reflecting a 10% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $286.85 million, up 7.8% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $0.51 per share and revenue of $1.19 billion, indicating changes of +13.33% and +10.44%, respectively, compared to the previous year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Lightspeed Commerce Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. At present, Lightspeed Commerce Inc. boasts a Zacks Rank of #3 (Hold). Looking at valuation, Lightspeed Commerce Inc. is presently trading at a Forward P/E ratio of 22.75. This valuation marks a discount compared to its industry average Forward P/E of 29.09. Also, we should mention that LSPD has a PEG ratio of 1.39. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Internet - Software industry held an average PEG ratio of 2.22. The Internet - Software industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 61, which puts it in the top 25% of all 250+ industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lightspeed Commerce Inc. (LSPD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Los Angeles Times
an hour ago
- Los Angeles Times
John C. Harris, California horse breeder and owner of Harris Farms, dies at 81
John C. Harris, California horse-racing mogul, had a particular love for the thoroughbred breeding and racing sector of his company, Harris Farms. Multiple horses that were raised and trained at Coalinga-based Harris Farms went on to become national champions, including Tiznow, the 2000 Horse of the Year, and California Chrome, a national Hall of Fame racehorse. A close friend recounted Harris' reaction to the latter thoroughbred winning the 2014 Kentucky Derby. The moment California Chrome sprinted over the finish line, tears streamed down Harris' face. 'It was just knowing that his farm had such a major role,' said his good friend Doug Burge. 'It was probably the most fun we ever had.' Harris, who owned the multimillion-dollar agribusiness Harris Farms, has died. He was 81. Those who knew Harris described him as an acclaimed rancher, farmer and horse-racing enthusiast who devoted himself to his passions to the end. Harris Farms confirmed his death in a statement shared on July 3. No details, including cause of death, were provided. Harris was born on July 14, 1943, and resided in Fresno County all of his life. He earned a degree in agricultural production at UC Davis before serving in the U.S. Army for two years. Harris took ownership of Harris Farms following his father's death in 1981. He oversaw all operations of the ranch, which encompasses a thriving farm that produces more than 30 types of crops including garlic, pistachios and wine grapes, as well as the horse-breeding operation, according to its website. Harris Farms was known for the beef it produced, but the cattle-raising portion of the business was sold in 2019. Harris nurtured a steadfast passion for horse racing and the thoroughbred breeding industry in Northern California, according to friends and family. He was a former president and board member of the California Thoroughbred Breeders Assn. and served on the board of the Thoroughbred Owners of California and the National Jockey Club. According to those who worked with him, he shaped the horse-racing industry into what it is today. 'He had a love for the land, everything from farming to raising horses,' said Burge, the current president of the CTBA, who knew Harris as a mentor and friend for more than 30 years. Harris was a longtime, dedicated advocate for the agricultural industry, according to Oscar Gonzalez, the vice chairman of the California Horse Racing Board who previously served as assistant secretary of Agriculture during the Biden administration. 'Mr. Harris was just a phone call away,' he said. 'When I was in Washington, D.C. ... and I needed a point of reference or background information on an issue involving agriculture, or water or immigration, he was always somebody that had context in that background.' One of Harris' last advocacy efforts was just a couple of weeks ago, when he fought to reinstate live horse racing at the Big Fresno Fair, a proposal that was ultimately unsuccessful. 'We will never give up continuing this storied tradition of Fresno racing. Today's story is not the end — we will come back again next year,' Harris said, according to the Business Journal. Justin Oldfield, a thoroughbred breeder and a chairman of the CTBA, said that Harris wanted everyone in the industry to be successful, always offering mentorship and help to those who needed it. 'For as successful as a businessman as he was, you would have never have known it from the way he treated you,' Oldfield said. 'John was an extremely humble, down-to-earth individual that treated everyone with respect, treated everyone like they had value.' He said that he once went to a horse racing industry event honoring Harris with more than 3,000 attendees. 'I can't even imagine how many people are gonna be at his funeral,' Oldfield said. Harris is survived by his wife, Cookie, and others 'whose lives were enriched by his strength of character and enduring compassion,' the statement from Harris Farms said.
